secretion by NK cells, may mediate inactivation of immunoregulatory receptors and functions as a regulator of NF-κB activation. Increased SHP-2 activity is involved in SLE pathogenesis, modulating T cell proliferation and downstream cytokine production. Here, NFKB1 is linked to systemic lupus erythematosus.